FDA Inspection 1089589 — Colgate-Palmolive India Ltd.

Colgate-Palmolive India Ltd. — FEI 3004698222

The FDA completed an inspection of Colgate-Palmolive India Ltd. on May 3, 2019 in Mumbai. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 3, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Mumbai (India)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
240121 CFR 211.194(a)(4)Complete Test Data